
Inhibikase Therapeutics, Inc.
USD2.23
+0.00 (+0.00%)
CEO
Mark T. Iwicki
IPO Date
2020-12-23
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$2.23
Prev. Close
$2.23
Day Low
$2.19
Day High
$2.31
52W Low
$1.33
52W High
$2.36
Market Cap
$0.29B
Volume
0.89M
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock